Adam Kaczorowski

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance.

Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance.

Journal: Diagnostics (Basel, Switzerland)
Published: January 20, 2026

Prognostic impact of spatial niches in prostate cancer.

Prognostic impact of spatial niches in prostate cancer.

Journal: Scientific reports
Published: October 08, 2025

Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer.

Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer.

Journal: Frontiers in oncology
Published: February 06, 2025

Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study.

Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study.

Journal: Frontiers in oncology
Published: December 24, 2024

Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler.

Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler.

Journal: Immuno-oncology technology
Published: September 23, 2024

Immune landscape of renal cell carcinoma with metastasis to the pancreas.

Immune landscape of renal cell carcinoma with metastasis to the pancreas.

Journal: Urologic oncology
Published: February 20, 2024

Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD.

Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD.

Journal: Scientific reports
Published: February 15, 2024

PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study.

PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study.

Journal: Diagnostics (Basel, Switzerland)
Published: November 13, 2023

Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma.

Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma.

Journal: Cancers
Published: October 02, 2023

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.

Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.

Journal: Cancers
Published: June 21, 2023

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.

Journal: Cancer immunology, immunotherapy : CII
Published: October 14, 2022

Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer.

Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: April 13, 2022
Showing 1-12 of 31

Last Updated: 09/26/2026